Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment. [electronic resource]
Producer: 20200902Description: 1165-1174 p. digitalISSN:- 1179-1926
- Administration, Oral
- Adult
- Aged
- Female
- Humans
- Kidney -- physiopathology
- Male
- Metabolic Clearance Rate -- drug effects
- Middle Aged
- Neoplasms -- complications
- No-Observed-Adverse-Effect Level
- Phthalazines -- administration & dosage
- Piperazines -- administration & dosage
- Poly(ADP-ribose) Polymerase Inhibitors -- administration & dosage
- Renal Insufficiency -- etiology
- Safety
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.